STCBIO

Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

March 11, 2020NewsBy stcbio

bBHC ‘STRI’, US Patent Registration Regarding Nerve Cell Differentiation using Newly Elicited Pluripotent Stem Cell without Side Effects by Natural Compounds (nEPS)

[MK뉴스] 2019.03.28

bBHC ‘STRI’, US Patent Registration Regarding Nerve Cell Differentiation using Newly Elicited Pluripotent Stem Cell without Side Effects by Natural Compounds (nEPS)
View Detail: https://www.mk.co.kr/news/society/view/2019/03/188200/

BACK

Treatment of acute ischemic stroke by minimally manipulated umbilical cord-derived mesenchymal stem cells transplantation: A case report
August 24, 2021

Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report
August 24, 2021

Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: Three case reports and review of literature
August 24, 2021

No title
July 31, 2020

STRI PERFECTS STEM-CELL PLURIPOTENCY TO ENABLE 3D PRINTING OF HUMAN ORGANS
April 17, 2020

460 patents regarding nEPS are registered in 147 countries.
March 19, 2020